Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134183 · ClinicalTrials.gov registry record · Phase 4
24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E
A Phase 4 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT03134183 is a Phase 4 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 70 participants.
The verdict
NCT03134183, a Phase 4 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study aims to compare mifepristone and buccal misoprostol to mifepristone and vaginal misoprostol for cervical preparation for second trimester dilation and evacuation (D\&E).
Interventions
- DRUG Vaginal Misoprostol
- DRUG Buccal Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-11-19 |
| Est. Completion | 2017-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03134183
The ClinicalTrials.gov registry entry for NCT03134183 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vaginal Misoprostol is the first listed.
NCT03134183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03134183 about?
NCT03134183 is a clinical study titled "24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E". This study aims to compare mifepristone and buccal misoprostol to mifepristone and vaginal misoprostol for cervical preparation for second trimester dilation and evacuation (D\&E).
What is the current status of trial NCT03134183?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2016-11-19. Estimated completion is 2017-08-01.
What interventions are being tested in trial NCT03134183?
The interventions under investigation include: Vaginal Misoprostol (DRUG), Buccal Misoprostol (DRUG).
Who is sponsoring clinical trial NCT03134183?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.